header-logo header-logo

Home Login E-newsletter About us

Problems on an industrial scale

© Copyright LexisNexis 2025. All Rights Reserved.
06 December 2018 / Vijay Ganapathy
Issue: 7820 / Categories: Features , Personal injury , Employment
printer mail-detail

Vijay Ganapathy considers how courts are tackling the issues associated with the treatment & costs of industrial diseases

  • New treatment options for mesothelioma sufferers.
  • Scope of vicarious liability.

The last few months have seen the courts determining some interesting issues relating to industrial disease. The Court of Appeal also considered whether to overturn a first instance decision on vicarious liability.

Immunotherapy

Starting with industrial disease, a topic currently attracting considerable attention in many asbestos disease cases is immunotherapy and how the costs of this relatively new treatment can be recovered by claimants.

Exposure to asbestos can cause mesothelioma which is a terminal cancer affecting the lining of the lungs. The choice of treatment for this condition has been quite limited so the possibility of undergoing immunotherapy has given many sufferers considerable hope.

Immunotherapy has been available for treatment of other types of cancer and recently, the National Institute for Health and Care Excellence (NICE) approved the use of two immunotherapy drugs for lung cancer patients. NICE are yet to provide similar

If you are not a subscriber, subscribe now to read this content
If you are already a subscriber sign in
...or Register for two weeks' free access to subscriber content

MOVERS & SHAKERS

Read All
Sponsored by
DWF—19 appointments

DWF—19 appointments

Belfast team bolstered by three senior hires and 16 further appointments

Cadwalader—Andro Atlaga

Cadwalader—Andro Atlaga

Firm strengthens leveraged finance team with London partner hire

Knights—Ella Dodgson & Rebecca Laffan

Knights—Ella Dodgson & Rebecca Laffan

Double hire marks launch of family team in Leeds

NEWS
Read All
NLJ this week: Traders’ convictions quashed in Libor shock
The Supreme Court issued a landmark judgment in July that overturned the convictions of Tom Hayes and Carlo Palombo, once poster boys of the Libor and Euribor scandal. In NLJ this week, Neil Swift of Peters & Peters considers what the ruling means for financial law enforcement
NLJ this week: Pro bono power without the red tape
Bea Rossetto of the National Pro Bono Centre makes the case for ‘General Practice Pro Bono’—using core legal skills to deliver life-changing support, without the need for niche expertise—in this week's NLJ
NLJ this week: DNA evidence—justice on ice?
In this week's NLJ, Steven Ball of Red Lion Chambers unpacks how advances in forensic science finally unmasked Ryland Headley, jailed in 2025 for the 1967 rape and murder of 75-year-old Louisa Dunne. Preserved swabs and palm prints lay dormant for decades until DNA-17 profiling produced a billion-to-one match
NLJ this week: Small firms call for tech clarity as AI looms
Small law firms want to embrace technology but feel lost in a maze of jargon, costs and compliance fears, writes Aisling O’Connell of the Solicitors Regulation Authority in this week's NLJ
NLJ this week: Fraud claims climb as courts brace for AI threats
Charlie Mercer and Astrid Gillam of Stewarts crunch the numbers on civil fraud claims in the English courts, in this week's NLJ. New data shows civil fraud claims rising steadily since 2014, with the King’s Bench Division overtaking the Commercial Court as the forum of choice for lower-value disputes
Copyright © 2025 LexisNexis
back-to-top-scroll